pyridine has been researched along with Idiopathic Parkinson Disease in 4 studies
azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, as well as the accumulation of intraneuronal proteinaceous inclusions known as Lewy bodies and Lewy neurites." | 1.72 | The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains. ( Manglano-Artuñedo, Z; Outeiro, TF; Peña-Díaz, S; Pinheiro, F; Pujols, J; Santos, J; Vasili, E; Ventura, S, 2022) |
| "Impulsive-compulsive disorders in Parkinson's disease patients have been described as behavioural or substance addictions including pathological gambling or compulsive medication use of dopamine replacement therapy." | 1.46 | Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease. ( Dardou, D; Durif, F; Fleurance, R; Gryshkova, V; Hafidi, A; Loiodice, S; McGhan, P; Nogueira da Costa, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peña-Díaz, S | 1 |
| Pujols, J | 1 |
| Vasili, E | 1 |
| Pinheiro, F | 1 |
| Santos, J | 1 |
| Manglano-Artuñedo, Z | 1 |
| Outeiro, TF | 1 |
| Ventura, S | 1 |
| Loiodice, S | 1 |
| McGhan, P | 1 |
| Gryshkova, V | 1 |
| Fleurance, R | 1 |
| Dardou, D | 1 |
| Hafidi, A | 1 |
| Nogueira da Costa, A | 1 |
| Durif, F | 1 |
| Fujita, M | 1 |
| Ichise, M | 1 |
| Zoghbi, SS | 1 |
| Liow, JS | 1 |
| Ghose, S | 1 |
| Vines, DC | 1 |
| Sangare, J | 1 |
| Lu, JQ | 1 |
| Cropley, VL | 1 |
| Iida, H | 1 |
| Kim, KM | 1 |
| Cohen, RM | 1 |
| Bara-Jimenez, W | 1 |
| Ravina, B | 1 |
| Innis, RB | 1 |
| BERGER, FM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Quantification of Cerebral Cholinergic Function in Patients With Parkinson´s Disease by Means of Nuclear Medicine Methods[NCT01003535] | 25 participants (Actual) | Observational | 2010-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for pyridine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains.
Topics: alpha-Synuclein; Amyloid; Humans; Lewy Bodies; Neuroprotective Agents; Parkinson Disease; Polymeriza | 2022 |
Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Benzothiazoles; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonis | 2017 |
Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.
Topics: Aged; Azetidines; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Pyridi | 2006 |
The treatment of paralysis agitans with thephorin.
Topics: Colon; Digestive System Surgical Procedures; Intestines; Parkinson Disease; Pyridines | 1949 |